glp 1 adherence GLP-1 therapies and mortality risk: Implications for life insurers New studies continue to show

Use clean tools when measuring and mixing to reduce contamination risk

For muscle growth, lab data and animal studies show that certain peptides stimulate the pituitary gland to release natural pulses of growth hormone

Researchers theorize this may be because: GIP activation may counterbalance some GLP-1 effects on the gut Dose escalation schedule allows more gradual adaptation Different pharmacokinetic profile may produce less pronounced peaks Serious Side Effects (Both Medications): These are rare but require immediate medical attention: Pancreatitis: Severe abdominal pain that may radiate to the back Risk: Less than 1% with both medications Usually occurs in first few months of treatment Requires immediate discontinuation if suspected Gallbladder Problems: Gallstones, cholecystitis (gallbladder inflammation) Symptoms: Right upper abdominal pain, nausea, fever More common with rapid weight loss May require surgical intervention Kidney Problems: Dehydration from vomiting/diarrhea can affect kidney function Watch for decreased urination, swelling in legs Stay well-hydrated, especially during side effect periods Thyroid Tumors (Black Box Warning): Both medications carry warnings about thyroid C-cell tumors Based on rodent studies

European Journal of Clinical Nutrition advance online publication, 30 August 2017

A.AndreuA.BarkerH.BlundellS.CampbellA.CampbellM.et al